Cargando…
Synthesis and Preliminary Evaluation of a Novel (18)F-Labeled 2-Nitroimidazole Derivative for Hypoxia Imaging
OBJECTIVE: Hypoxia is prevalent in tumors and plays a pivotal role in resistance to chemoradiotherapy. (18)F-MISO ((18)F-labeled fluoromisonidazole) is currently the preferred choice of PET hypoxia tracers in clinical practice, but has severe disadvantages involving complex labeling methods and low...
Autores principales: | Lu, Jing, Zhang, Chi, Yang, Xi, Yao, Xi-Juan, Zhang, Qun, Sun, Xin-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884749/ https://www.ncbi.nlm.nih.gov/pubmed/33604284 http://dx.doi.org/10.3389/fonc.2020.572097 |
Ejemplares similares
-
2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging—Investigation of Nucleoside Transporter Interaction, (18)F-Labeling and Preclinical PET Imaging
por: Maier, Florian C., et al.
Publicado: (2019) -
Synthesis and Evaluation of (99m)Tc-Labelled 2-Nitroimidazole Derivatives with Different Linkers for Tumour Hypoxia Imaging
por: Ruan, Qing, et al.
Publicado: (2023) -
Preparation and Bioevaluation of Novel (99m)Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
por: Ruan, Qing, et al.
Publicado: (2021) -
Synthesis of a 2-nitroimidazole derivative N-(4-[(18)F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([(18) F]FBNA) as PET radiotracer for imaging tumor hypoxia
por: Nario, Arian Pérez, et al.
Publicado: (2022) -
Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
por: Wei, Huiqiang, et al.
Publicado: (2016)